Kenneth M. Bahrt
Equibles does not estimate personal net worth.
Get an email with a short summary when Outlook Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get OTLK alertsAbout Kenneth M. Bahrt
The proxy statement of Outlook Therapeutics, Inc. reports total compensation of $1,625,250 for Kenneth M. Bahrt in fiscal 2019, including a base salary of $240,000. Disclosed compensation is on record for 2 fiscal years. Outlook Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Outlook Therapeutics, Inc. includes Robert C. Jahr (CEO and Board Member), Robert Charles Jahr (CEO and Board Member), Faisal G. Sukhtian (Chairman) and 7 others.
Affiliation history
-
Outlook Therapeutics, Inc. (OTLK)
Proxy statement
Current
Company network
Leadership on record at Outlook Therapeutics, Inc.
- Robert C. Jahr CEO, Board Member
- Robert Charles Jahr CEO, Board Member
- Faisal G. Sukhtian Chairman
- Kevin Lundquist CFO
- Lawrence Kenyon CFO, Board Member
- LawrenceA. Kenyon CFO
- Terry Dagnon COO
- Andong Huang Board Member
- Dr. Julia A. Haller Board Member
- Gerd Auffarth Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Outlook Therapeutics, Inc. (OTLK) | Former Chief Medical Officer | $240,000 | $1,625,250 |
| 2018 | Outlook Therapeutics, Inc. (OTLK) | Former Chief Medical Officer | $400,000 | $429,082 |
Recent activity
No call appearances or filed executive changes recorded yet.